PRADAXA caps 110 mg 3 x 60 pce

7680613850167 CH-61385 B01AE07 06.03.0.
PRADAXA caps 110 mg 3 x 60 pce
PRADAXA caps 110 mg 3 x 60 pce
1 / 2
google

Details

Product number
6138502
CPT
-
Packaging group
3 x 60
Unit
Kapsel(n)
Composition
dabigatranum etexilatum 110 mg ut dabigatrani etexilati mesilas 126.83 mg, acaciae gummi, acidum tartaricum, hypromellosum, dimeticonum, talcum, hydroxypropylcellulosum, Kapselhülle: hypromellosum, carrageenanum, kalii chloridum, E 171, E 132, aqua purificata, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Pradaxa 110 mg, Kapseln
Kapseln
3 x 60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/02/2024
Patient information leaflet
Français
26/02/2024
Patient information leaflet
Italien
26/02/2024
Professional SmPC
Allemand
26/02/2024
Professional SmPC
Français
26/02/2024
Professional SmPC
Italien
26/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
110.0 MG Substance Wirkstoff (Principe actif)
(N/A)
126.83 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 181.60
Specialties list
Yes
Generic
No
SL addition date: 01/12/2013

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
61385
Drug name
Pradaxa, Kapseln
Galenic form
KAPS
ATC Code
B01AE07
Authorization status
Z
Dispensation category
B
First authorization
29/05/2012
Authorization expiration date
31/12/9999
IT number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Packaging details

Description (FR)
PRADAXA caps 110 mg 3 x 60 pce
Description (DE)
PRADAXA Kaps 110 mg 3 x 60 Stk
Market launch
29/05/2012
Narcotic (BTM)
No

Available generics

Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580015
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580022
CHF 150.10
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580039
CHF 60.95
View
Dabigatran Sandoz, Hartkapseln
GTIN: 7680686580046
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550011
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550028
CHF 150.10
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550035
CHF 60.95
View
Dabigatran Spirig HC, Hartkapseln
GTIN: 7680690550042
CHF 150.10
View

Other packaging sizes

PRADAXA caps 110 mg 60 pce
60 KAP
GTIN: 7680613850150
View